- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06250712
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia (HELP-A)
July 18, 2026 updated by: Young Jun Park, Wonju Severance Christian Hospital
The HELP-A study is a multicenter, randomized, controlled trial.
A total of 588 patients were enrolled during the 4-year enrollment period and followed for 1 month.
This study aims to compare the diagnostic yield of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The HELP-A study is a multicenter, randomized, controlled trial designed to compare the diagnostic yield, arrhythmia detection rate, user convenience, and cost-effectiveness of a continuous ECG patch versus an intermittent handheld ECG in patients with arrhythmia symptoms.
The study enrolls patients who have symptoms suggestive of arrhythmia but remain undiagnosed on a 12-lead ECG and require additional testing.
A total of 588 patients will be enrolled during the 4-year enrollment period and followed for 3 months.
Patients will be randomly assigned to either a continuous patch ECG or an intermittent handheld ECG and monitored for one month.
If no diagnosis is made after one month, patients will cross over to the other device and be monitored for an additional month.
Study Type
Interventional
Enrollment (Estimated)
588
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Young Park, MD
- Phone Number: 82-2-920-5445
- Email: yjparkcardio@gmail.com
Study Locations
-
-
-
Seoul, South Korea
- Recruiting
- Korea anam hospital
-
Contact:
- Young Jun Park
- Phone Number: 82-2-920-5445
- Email: yjparkcardio@gmail.com
-
-
Dong-gu Jaebongro 42
-
Gwangju, Dong-gu Jaebongro 42, South Korea, 61469
- Recruiting
- Chonnam National University Hospital
-
Contact:
- Ki hong Lee, MD
- Phone Number: 82 01-9962-5830
- Email: drgood2@naver.com
-
-
Gangwon-do
-
Wŏnju, Gangwon-do, South Korea, 26426
- Recruiting
- Wonju Severance Christian Hospital
-
Contact:
- Min-Soo Ahn
- Email: heartsaver@yonsei.ac.kr
-
-
Hwaseong-si Keunjaebong-gil 7
-
Gyeonggi-do, Hwaseong-si Keunjaebong-gil 7, South Korea, 18450
- Recruiting
- Hallym University Dongtan Sacred Heart Hospital
-
Contact:
- Seong Woo Han Professor, MD
- Phone Number: 82 01-2630-6489
- Email: hansw29@hallym.or.kr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
- Patients who can use a smartphone
Exclusion Criteria:
- Patients who have cardiac implantable electronic devices(CIEDs)
- Patients who can't use handheld ECG
- Patient who had syncope
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Continous ECG Patch
In this arm, continuous patch ECG was used.
|
Using a continuous patch ECG for 1 week during 1 month
|
|
Active Comparator: Intermittent handheld ECG
In this arm, intermittent handheld ECG was used.
|
Using a handheld ECG twice daily and when symptoms are present during 1 month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic yield
Time Frame: 1 month
|
(Number of patient with triggered event without arrhythmia + Number of patients with clnically significant arrhytmia) / total patients
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arrhythmia detection rate
Time Frame: 3 month
|
Compare the arrhythmia diagnosis rate between the two devices.
|
3 month
|
|
Cost-effectiveness
Time Frame: 3 month
|
Compare Total medical cost incurred for arrhythmia symptoms between the two devices
|
3 month
|
|
Chagne of Quality of Life
Time Frame: Baseline, 3 month
|
Compare Quality Of Life using Euro QOL-5D-5L between the two devices
|
Baseline, 3 month
|
|
User convenience
Time Frame: 3 month
|
Comparison of User convenience using questionnaires in patients who used both devices (ease, portability, satisfaction, etc.)
The questionnaire consists of 5 scales from 1 to 5
|
3 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Young Jun Park, MD, Wonju Severance Christian Hopsital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Schreiber D, Sattar A, Drigalla D, Higgins S. Ambulatory cardiac monitoring for discharged emergency department patients with possible cardiac arrhythmias. West J Emerg Med. 2014 Mar;15(2):194-8. doi: 10.5811/westjem.2013.11.18973.
- Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L, Morgan JM, Raatikainen MJ, Steinbeck G, Viskin S, Kirchhof P, Braunschweig F, Borggrefe M, Hocini M, Della Bella P, Shah DC; European Heart Rhythm Association. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011 Jul;13(7):920-34. doi: 10.1093/europace/eur130. No abstract available.
- Turnbull S, Garikapati K, Bennett RG, Campbell TG, Kotake Y, Mahajan R, Marschner S, Byth K, Chow CK, Kumar S. Utility of a Handheld, Single-Lead ECG Device for Diagnosis of Cardiac Arrhythmias. J Am Coll Cardiol. 2023 Jun 13;81(23):2292-2294. doi: 10.1016/j.jacc.2023.03.428. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 22, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
January 31, 2024
First Submitted That Met QC Criteria
February 7, 2024
First Posted (Actual)
February 9, 2024
Study Record Updates
Last Update Posted (Actual)
July 21, 2026
Last Update Submitted That Met QC Criteria
July 18, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR223024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
Fayoum University HospitalRecruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Arrhythmia | Heart Failure, Congestive | Sinus Arrhythmia
-
Boston Scientific CorporationNot yet recruitingAtrial Arrhythmia | Intracardiac EchocardiographyNew Zealand, Malaysia, Greece, Croatia, Singapore, Poland, Czechia, Australia
-
Ceryx Medical AustraliaAvaniaRecruitingHeart Failure With Reduced Ejection FractionAustralia, New Zealand
-
Ceryx Medical LtdCardiff and Vale University Health BoardRecruitingHeart Failure With Reduced Ejection FractionUnited Kingdom
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationRecruiting
-
University of UtahAltaThera Pharmaceuticals, LLCCompleted
-
Universitätsklinikum KölnUnknown
Clinical Trials on Continous ECG Patch
-
HUINNO Co., LtdCompletedHeart Diseases | Cardiac Surgery | Cardiac ArrhythmiasSouth Korea
-
Population Health Research InstituteHeart and Stroke Foundation of Canada; Canadian Cardiovascular SocietyCompletedHeart Failure | Atrial FibrillationCanada
-
AstraZenecaCompletedAcute Decompensated Heart FailureUnited Kingdom
-
Yonsei UniversityRecruitingPatient With Atrial Fibrillation or High Stroke RiskKorea, Republic of
-
Massachusetts General HospitalEnrolling by invitationAtrial Fibrillation (AF)United States
-
Apple Inc.IQVIA Pty LtdCompleted
-
Fitbit IncCompletedAtrial FibrillationUnited States
-
Beijing Anzhen HospitalNot yet recruiting
-
Charite University, Berlin, GermanyNot yet recruitingArrhythmias, Cardiac | Heart Arrest | Electrocardiography
-
Sorlandet Hospital HFRecruitingIschemic Stroke | Atrial Fibrillation (AF) | Secondary Prevention | Arrhythmia Atrial | Atrial Fibrillation (Prevention of Stroke)Norway